{
    "lungNodes": [
        {
            "nodesToFollow": [1, 5],
            "node": 0,
            "name": "Lung Cancer",
            "desc": "A malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body"
        },
        {
            "nodesToFollow": [2, 3],
            "node": 1,
            "name": "Small Cell",
            "desc": "Small cell lung cancer (SCLC) is a fast-growing type of lung cancer. It spreads much more quickly than non-small cell lung cancer. There are two types of SCLC: Small cell carcinoma (oat cell cancer) and Combined small cell carcinoma"
        },
        {
            "nodesToFollow": [],
            "node": 2,
            "name": "Limited",
            "desc": "Limited stage means that the cancer is only in 1 part of the chest and radiation therapy could be a treatment option. About 1 out of 3 people with SCLC have limited stage disease when first diagnosed."
        },
        {
            "nodesToFollow": [4],
            "node": 3,
            "name": "Extensive",
            "desc": "Extensive stage small cell lung cancer is defined as the stage during which the cancer has metastasized (spread) to other parts of the body, such as the lung or brain. The liver, adrenal glands, and bone are also common sites of metastasis."
        },
        {
            "nodesToFollow": [],
            "node": 4,
            "name": "Maintenance",
            "desc": ""
        },
        {
            "nodesToFollow": [6, 8],
            "node": 5,
            "name": "Non-Small",
            "desc": "Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers."
        },
        {
            "nodesToFollow": [7],
            "node": 6,
            "name": "Resectable",
            "desc": "Resectable means you can get surgery to treat it."
        },
        {
            "nodesToFollow": [],
            "node": 7,
            "name": "Adjuvant Therapy",
            "desc": "A therapy that is given in addition to the primary or initial therapy to maximize its effectiveness. The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments. "
        },
        {
            "nodesToFollow": [9, 10, 11],
            "node": 8,
            "name": "Unresectable",
            "desc": "Unresectable means you can't get surgery to treat it. It might be because your tumor is in a hard-to-reach spot or for other reasons."
        },
        {
            "nodesToFollow": [],
            "node": 9,
            "name": "First Line",
            "desc": "First line therapy is the treatment regimen or regimens that are generally accepted by the medical establishment for initial treatment of a given type and stage of cancer. It is also called primary treatment or therapy."
        },
        {
            "nodesToFollow": [],
            "node": 10,
            "name": "Second Line",
            "desc": "Second-line therapies are those tried when the first ones may have had some limited efficacy, or may have produced unacceptable side effects, damaged organs in the body, or jeopardized the patient’s life."
        },
        {
            "nodesToFollow": [],
            "node": 11,
            "name": "Third Line",
            "desc": "Treatment that is given when both initial treatment (first-line therapy) and subsequent treatment (second-line therapy) don't work, or stop working."
        }
    ],
    "skinNodes": [
        {
            "nodesToFollow": [1, 2, 6],
            "node": 0,
            "name": "Skin Cancer",
            "desc": "Skin cancers are cancers that arise from the skin. They are due to the development of abnormal cells that have the ability to invade or spread to other parts of the body. There are three main types of skin cancers: basal-cell skin cancer (BCC), squamous-cell skin cancer (SCC) and melanoma."
        },
        {
            "nodesToFollow": [],
            "node": 1,
            "name": "Melanoma",
            "desc": "Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye."
        },
        {
            "nodesToFollow": [3, 4, 5],
            "node": 2,
            "name": "Resectable",
            "desc": "Resectable means you can get surgery to treat it."
        },
        {
            "nodesToFollow": [],
            "node": 3,
            "name": "First Line",
            "desc": "First line therapy is the treatment regimen or regimens that are generally accepted by the medical establishment for initial treatment of a given type and stage of cancer. It is also called primary treatment or therapy."
        },
        {
            "nodesToFollow": [5],
            "node": 4,
            "name": "Second Line",
            "desc": "Second-line therapies are those tried when the first ones may have had some limited efficacy, or may have produced unacceptable side effects, damaged organs in the body, or jeopardized the patient’s life."
        },
        {
            "nodesToFollow": [],
            "node": 5,
            "name": "Third Line",
            "desc": "Treatment that is given when both initial treatment (first-line therapy) and subsequent treatment (second-line therapy) don't work, or stop working."
        },
        {
            "nodesToFollow": [7, 8, 9, 10],
            "node": 6,
            "name": "Unresectable",
            "desc": "Unresectable means you can't get surgery to treat it. It might be because your tumor is in a hard-to-reach spot or for other reasons."
        },
        {
            "nodesToFollow": [],
            "node": 7,
            "name": "First Line",
            "desc": "First line therapy is the treatment regimen or regimens that are generally accepted by the medical establishment for initial treatment of a given type and stage of cancer. It is also called primary treatment or therapy."
        },
        {
            "nodesToFollow": [],
            "node": 8,
            "name": "Second Line",
            "desc": "Second-line therapies are those tried when the first ones may have had some limited efficacy, or may have produced unacceptable side effects, damaged organs in the body, or jeopardized the patient’s life."
        },
        {
            "nodesToFollow": [],
            "node": 9,
            "name": "Third Line",
            "desc": "Treatment that is given when both initial treatment (first-line therapy) and subsequent treatment (second-line therapy) don't work, or stop working."
        },
        {
            "nodesToFollow": [],
            "node": 10,
            "name": "Metastatic",
            "desc": "Metastatic cancer is commonly called stage IV cancer or advanced cancer. It occurs when cancer cells break off from the original tumor, spread through the bloodstream or lymph vessels to another part of the body, and form new tumors."
        }
    ],
    "breastNodes": [
        {
            "nodesToFollow": [1, 5, 10, 12, 13],
            "node": 0,
            "name": "Breast Cancer",
            "desc": "Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly-inverted nipple, or a red or scaly patch of skin."
        },
        {
            "nodesToFollow": [2, 4],
            "node": 1,
            "name": "Neoadjuvant",
            "desc": "Neoadjuvant therapy treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy. It is a type of induction therapy."
        },
        {
            "nodesToFollow": [3],
            "node": 2,
            "name": "HER2+",
            "desc": "HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), which promotes the growth of cancer cells."
        },
        {
            "nodesToFollow": [],
            "node": 3,
            "name": "Early Breast Cancer",
            "desc": "early-stage breast cancer is the breast cancer that has not spread beyond the breast or the axillary lymph nodes. This includes ductal carcinoma in situ and stage I, stage IIA, stage IIB, and stage IIIA breast cancers."
        },
        {
            "nodesToFollow": [],
            "node": 4,
            "name": "HER2-",
            "desc": "HER2-negative means that the cancerous cells do not contain high levels of the protein HER2. There are many treatment options available for this type of breast cancer, but the prognosis can vary."
        },
        {
            "nodesToFollow": [6, 7],
            "node": 5,
            "name": "Adjuvant",
            "desc": "A therapy that is given in addition to the primary or initial therapy to maximize its effectiveness. The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments."
        },
        {
            "nodesToFollow": [],
            "node": 6,
            "name": "HER2+",
            "desc": "HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), which promotes the growth of cancer cells."
        },
        {
            "nodesToFollow": [8],
            "node": 7,
            "name": "HER2-",
            "desc": "HER2-negative means that the cancerous cells do not contain high levels of the protein HER2. There are many treatment options available for this type of breast cancer, but the prognosis can vary."
        },
        {
            "nodesToFollow": [9],
            "node": 8,
            "name": "Hormone Receptor Positive",
            "desc": "Hormone receptor-positive (or hormone-positive) breast cancer cells have either estrogen (ER) or progesterone (PR) receptors or both. These breast cancers can be treated with hormone therapy drugs that lower estrogen levels or block estrogen receptors."
        },
        {
            "nodesToFollow": [],
            "node": 9,
            "name": "Early Breast Cancer",
            "desc": "early-stage breast cancer is the breast cancer that has not spread beyond the breast or the axillary lymph nodes. This includes ductal carcinoma in situ and stage I, stage IIA, stage IIB, and stage IIIA breast cancers."
        },
        {
            "nodesToFollow": [11],
            "node": 10,
            "name": "Metastatic",
            "desc": "Metastatic cancer is commonly called stage IV cancer or advanced cancer. It occurs when cancer cells break off from the original tumor, spread through the bloodstream or lymph vessels to another part of the body, and form new tumors."
        },
        {
            "nodesToFollow": [],
            "node": 11,
            "name": "Triple Negatice or HER2+",
            "desc": "A diagnosis of triple negative breast cancer means that the three most common types of receptors known to fuel most breast cancer growth–estrogen, progesterone, and the HER-2/neu gene– are not present in the cancer tumor. HER2+ breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), which promotes the growth of cancer cells."
        },
        {
            "nodesToFollow": [],
            "node": 12,
            "name": "Second Line",
            "desc": "Second-line therapies are those tried when the first ones may have had some limited efficacy, or may have produced unacceptable side effects, damaged organs in the body, or jeopardized the patient’s life."
        },
        {
            "nodesToFollow": [14],
            "node": 13,
            "name": "Other",
            "desc": "Other"
        },
        {
            "nodesToFollow": [],
            "node": 14,
            "name": "High Risk for Chemo induced nausea",
            "desc": "High Risk for Chemo induced nausea and vomiting."
        }
    ],
    
    "urinaryNodes": [
        {
            "nodesToFollow": [1, 8, 21],
            "node": 0,
            "name": "Genito-Urinary Cancer",
            "desc": "Genitourinary cancers is a specialised field focusing on cancers found in the urinary system and the male reproductive system. These include prostate cancer, kidney cancer, bladder cancer, testicular cancer and cancers of the penis."
        },
        {
            "nodesToFollow": [2, 6],
            "node": 1,
            "name": "Renal Cell Carcinoma",
            "desc": "Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport primary urine."
        },
        {
            "nodesToFollow": [3, 4],
            "node": 2,
            "name": "Adjuvant",
            "desc": "A therapy that is given in addition to the primary or initial therapy to maximize its effectiveness. The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments."
        },
        {
            "nodesToFollow": [],
            "node": 3,
            "name": "Post Nephrectomy",
            "desc": "Nephrectomy is the surgical removal of a kidney. The procedure is done to treat kidney cancer as well as other kidney diseases and injuries."
        },
        {
            "nodesToFollow": [5],
            "node": 4,
            "name": "Localized",
            "desc": "localized."
        },
        {
            "nodesToFollow": [],
            "node": 5,
            "name": "High Risk of Relapse",
            "desc": "High Risk of Relapse post partial/radical nephrectomy."
        },
        {
            "nodesToFollow": [7],
            "node": 6,
            "name": "Line 1-2-3",
            "desc": "Line 1-2-3."
        },
        {
            "nodesToFollow": [],
            "node": 7,
            "name": "Advanced Renal Cell Carcinoma",
            "desc": "Advanced Renal Cell Carcinom means the cancer has spread either into a major vein, to lymph nodes, or to other organs"
        },
        {
            "nodesToFollow": [9, 10],
            "node": 8,
            "name": "Prostate",
            "desc": "The prostate is a part of the male reproductive system. It adds nutrients and fluid to sperm. Normally the size of a walnut, the prostate can be divided into right and left lobes.It is located in front of the rectum, just below the bladder."
        },
        {
            "nodesToFollow": [],
            "node": 9,
            "name": "Adjuvant",
            "desc": "A therapy that is given in addition to the primary or initial therapy to maximize its effectiveness. The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments."
        },
        {
            "nodesToFollow": [11, 15],
            "node": 10,
            "name": "Metastatic",
            "desc": "Metastatic cancer is commonly called stage IV cancer or advanced cancer. It occurs when cancer cells break off from the original tumor, spread through the bloodstream or lymph vessels to another part of the body, and form new tumors."
        },
        {
            "nodesToFollow": [12, 13, 14],
            "node": 11,
            "name": "Hormone Sensitive",
            "desc": "A hormone-sensitive cancer, or hormone-dependent cancer, is a type of cancer that is dependent on a hormone for growth and/or survival."
        },
        {
            "nodesToFollow": [],
            "node": 12,
            "name": "First Line",
            "desc": "First line therapy is the treatment regimen or regimens that are generally accepted by the medical establishment for initial treatment of a given type and stage of cancer. It is also called primary treatment or therapy."
        },
        {
            "nodesToFollow": [],
            "node": 13,
            "name": "Second Line",
            "desc": "Second line therapies are those tried when the first ones may have had some limited efficacy, or may have produced unacceptable side effects, damaged organs in the body, or jeopardized the patient’s life."
        },
        {
            "nodesToFollow": [],
            "node": 14,
            "name": "Third Line",
            "desc": "Treatment that is given when both initial treatment (first-line therapy) and subsequent treatment (second-line therapy) don't work, or stop working."
        },
        {
            "nodesToFollow": [16, 18, 19],
            "node": 15,
            "name": "Castrate Resistant",
            "desc": "Castrate-resistant prostate cancer (CRPC) is defined by disease progression despite androgen depletion therapy (ADT) and may present as either a continuous rise in serum prostate-specific antigen (PSA) levels, the progression of pre-existing disease, and/or the appearance of new metastases."
        },
        {
            "nodesToFollow": [17],
            "node": 16,
            "name": "First Line",
            "desc": "First line therapy is the treatment regimen or regimens that are generally accepted by the medical establishment for initial treatment of a given type and stage of cancer. It is also called primary treatment or therapy."
        },
        {
            "nodesToFollow": [],
            "node": 17,
            "name": "ChemoTherapy Naive",
            "desc": " progressed on NG Hormonal Agent: Who have had little or no experience with chemotherapy"
        },
        {
            "nodesToFollow": [20],
            "node": 18,
            "name": "Second Line",
            "desc": "Second line therapies are those tried when the first ones may have had some limited efficacy, or may have produced unacceptable side effects, damaged organs in the body, or jeopardized the patient’s life."
        },
        {
            "nodesToFollow": [20],
            "node": 19,
            "name": "Third Line",
            "desc": "Treatment that is given when both initial treatment (first-line therapy) and subsequent treatment (second-line therapy) don't work, or stop working."
        },
        {
            "nodesToFollow": [],
            "node": 20,
            "name": "Associated Homologous Recombination Deficiency",
            "desc": "Homologous recombination is a DNA repair pathway of clinical interest due to the sensitivity of homologous recombination-deficient cells to poly-ADP ribose polymerase (PARP) inhibitors."
        },
        {
            "nodesToFollow": [22, 24],
            "node": 21,
            "name": "Bladder Cancer",
            "desc": "Bladder cancer is any of several types of cancer arising from the tissues of the urinary bladder."
        },
        {
            "nodesToFollow": [23],
            "node": 22,
            "name": "Cisplatin-eligible, Muscle-invasive",
            "desc": "Cisplatin-based chemotherapy is the first-line (1L) treatment for eligible patients with locally advanced/metastatic urothelial carcinoma (mUC)."
        },
        {
            "nodesToFollow": [],
            "node": 23,
            "name": "Neoadjuvant",
            "desc": "neoadjuvant therapy Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy."
        },
        {
            "nodesToFollow": [25, 26],
            "node": 24,
            "name": "Locally Advanced or Mets Urothelial",
            "desc": "Metastatic or unresectable disease is identified in approximately 20% of patients presenting with invasive urothelial cancer."
        },
        {
            "nodesToFollow": [],
            "node": 25,
            "name": "First Line",
            "desc": "First line therapy is the treatment regimen or regimens that are generally accepted by the medical establishment for initial treatment of a given type and stage of cancer. It is also called primary treatment or therapy."
        },
        {
            "nodesToFollow": [],
            "node": 26,
            "name": "Third Line",
            "desc": "Treatment that is given when both initial treatment (first-line therapy) and subsequent treatment (second-line therapy) don't work, or stop working."
        }
    ],
    "lungTrials": [
        {
            "name": "ABBVIE MERU M16-298",
            "pathToSuccessfulTrial": [0,1,3,4],
            "Availability": false
        },
        {
            "name": "(CCTG) BR.31",
            "pathToSuccessfulTrial": [0,5,6,7],
            "Availability": true
        },
        {
            "name": "(ROCHE) BO29554/BFAST",
            "pathToSuccessfulTrial": [0,5,8,9],
            "Availability": true
        },
        {
            "name": "BMS CA209-907",
            "pathToSuccessfulTrial": [0,5,8,10],
            "Availability": false
        }
    ],
    "breastTrials": [
        {
            "name": "(ROCHE) WO40324/ Fedrica",
            "pathToSuccessfulTrial": [0,1,2,3],
            "Availability": false   
        },
        {
            "name": "(NOVARTIS) CLEE011O12301C (NATALEE/TRIO033)",
            "pathToSuccessfulTrial": [0,5,7,8,9],
            "Availability": true
        },
        {
            "name": "(OHRI) The ILIAD Study",
            "pathToSuccessfulTrial": [0,13,14],
            "Availability": false
        }
    ],
    "skinTrials": [
        {
        "name": "(CCTG) ME.13/STOP-GAP",
        "pathToSuccessfulTrial": [0,6,10],
        "Availability": true
        }
    ],
    "urinaryTrials": [
        {
            "name": "(MERCK) MK-3475-564/KEYNOTE-564",
            "pathToSuccessfulTrial": [0,1,2,3],
            "Availability": false
        },
        {
            "name": "(BMS) CA209-914",
            "pathToSuccessfulTrial": [0,1,2,4,5],
            "Availability": true
        },
        {
            "name": "(BMS) CA018005/FRACTION-RCC",
            "pathToSuccessfulTrial": [0,1,6,7],
            "Availability": true
        },
        {
            "name": "(Merck) MK3475-641/KEYNOTE 641",
            "pathToSuccessfulTrial": [0,8,10,15,16,17],
            "Availability": true
        },
        {
            "name": "(Merck) MK3475-921/KEYNOTE 921",
            "pathToSuccessfulTrial": [0,8,10,15,16],
            "Availability": true
        },
        {
            "name": "(Clovis) TRITON 3/CO-338-063",
            "pathToSuccessfulTrial": [0,8,10,15,18,20],
            "Availability": true
        },
        {
            "name": "(Clovis) TRITON 3/CO-338-063",
            "pathToSuccessfulTrial": [0,8,10,15,19,20],
            "Availability": true
        },
        {
            "name": "(Merck) MK-7902-011",
            "pathToSuccessfulTrial": [0,21,24,25],
            "Availability": true
        },
        {
            "name": "(ASTELLAS) 7465-CL-0301",
            "pathToSuccessfulTrial": [0,21,24,26],
            "Availability": true
        }
    ]
}